- JP-listed companies
- 3-D Matrix,Ltd.
- Balance sheet
3-D Matrix,Ltd. (7777) Balance sheet
Market cap
¥54.7B
P/E ratio
59.2x
Three-D Matrix develops and sells medical devices and pharmaceuticals using exclusive MIT-licensed self-assembling peptide technology for surgery, tissue regeneration, and drug delivery.
| 2014/04 | 2015/04 | 2016/04 | 2017/04 | 2018/04 | 2019/04 | 2020/04 | 2021/04 | 2022/04 | 2023/04 | 2024/04 | 2025/04 | |
| Cash and cash equivalents | - | 5,137 | 3,512 | 1,748 | 1,162 | 1,803 | 1,058 | 1,138 | 2,849 | 1,171 | 1,364 | 1,580 |
| Total cash & short-term investments | - | 5,137 | 3,512 | 1,748 | 1,162 | 1,803 | 1,058 | 1,138 | 2,849 | 1,171 | 1,364 | 1,580 |
| Total current assets | - | 6,204 | 4,422 | 3,388 | 3,111 | 4,067 | 3,088 | 3,476 | 5,578 | 5,667 | 5,792 | 6,419 |
| Property, plant and equipment, net | - | 94 | - | - | - | - | - | - | - | - | - | - |
| Marketable securities, non-current | - | - | - | - | - | - | - | - | 1 | 7 | 8 | 8 |
| Total non-current assets | - | 605 | 38 | 35 | 25 | 26 | 27 | 32 | 33 | 158 | 95 | 94 |
| Total assets | - | 6,809 | 4,460 | 3,424 | 3,136 | 4,093 | 3,116 | 3,508 | 5,611 | 5,826 | 5,886 | 6,513 |
| Short-term debt | - | 200 | 200 | 450 | 450 | 550 | 400 | 408 | 400 | 500 | 300 | 300 |
| Total current liabilities | - | 409 | 524 | 816 | 934 | 1,280 | 1,242 | 774 | 867 | 1,303 | 1,537 | 1,579 |
| Total non-current liabilities | - | 18 | - | - | - | 1,300 | 1,401 | 1,075 | 3,286 | 3,998 | 3,996 | 2,718 |
| Total liabilities | - | 428 | 524 | 816 | 934 | 2,580 | 2,643 | 1,848 | 4,153 | 5,301 | 5,533 | 4,297 |
| Retained earnings | - | -5,787 | -8,246 | -9,638 | -11,505 | -14,059 | -17,155 | -19,168 | -21,063 | -23,509 | -23,764 | -26,265 |
| Stockholders' equity | 3,133 | 6,382 | 3,936 | 2,607 | 2,202 | 1,513 | 473 | 1,660 | 1,458 | 525 | 353 | 2,216 |